Eugene Braunwald

1968 National Institutes of Health, Bethesda, MD 
 1968-1972 University of California, San Diego School of Medicine, San Diego, CA, United States 
 1972- Harvard Medical School, Boston, MA, United States 
"Eugene Braunwald"


Sign in to add trainee
James W. Covell post-doc 1968 NIH (Chemistry Tree)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Jering KS, Claggett BL, Pfeffer MA, et al. (2023) Prognostic Importance of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Following High-Risk Myocardial Infarction in the PARADISE-MI Trial. Circulation. Heart Failure. e010259
Sabatine MS, Braunwald E. (2021) Thrombolysis In Myocardial Infarction (TIMI) Study Group: JACC Focus Seminar 2/8. Journal of the American College of Cardiology. 77: 2822-2845
Jering KS, Claggett B, Pfeffer MA, et al. (2021) Prospective ARNI vs. ACE inhibitor trial to DetermIne Superiority in reducing heart failure Events after Myocardial Infarction (PARADISE-MI): design and baseline characteristics. European Journal of Heart Failure
Berardi C, Braunwald E, Morrow DA, et al. (2020) Angiotensin-Neprilysin Inhibition in Black Americans: Data From the PIONEER-HF Trial. Jacc. Heart Failure
Antman EM, Braunwald E. (2020) Invasive or Conservative Strategy for Stable Coronary Disease. Reply. The New England Journal of Medicine. 383: e66
Ambrosy AP, Braunwald E, Morrow DA, et al. (2020) Angiotensin Receptor-Neprilysin Inhibition Based on History of Heart Failure and Use of Renin-Angiotensin System Antagonists. Journal of the American College of Cardiology. 76: 1034-1048
Berg DD, Braunwald E, DeVore AD, et al. (2020) Efficacy and Safety of Sacubitril/Valsartan by Dose Level Achieved in the PIONEER-HF Trial. Jacc. Heart Failure
Gaziano TA, Fonarow GC, Velazquez EJ, et al. (2020) Cost-effectiveness of Sacubitril-Valsartan in Hospitalized Patients Who Have Heart Failure With Reduced Ejection Fraction. Jama Cardiology
Marston NA, Bonaca MP, Jarolim P, et al. (2020) Clinical Application of High-Sensitivity Troponin Testing in the Atherosclerotic Cardiovascular Disease Framework of the Current Cholesterol Guidelines. Jama Cardiology
Mann DL, Greene SJ, Givertz MM, et al. (2020) Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction: Rationale and Design of the LIFE Trial. Jacc. Heart Failure
See more...